What is IART's current stock price?

As of now, IART is trading at $12.04, with a daily change of -0.41%.

What are the risks associated with IART stock?

IART Key risk is its Moderate, .

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

IART Stock Analysis & IQ Rating | Integra LifeSciences

IART

Integra LifeSciences

$12.04

-$0.05 | -0.41%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$ 27.13

MKT CAP

$ 937.82M

52W Low

$ 10.87

VOL

$ 836.18K

P/E Ratio

N/A

AVG VOL

$ 1.17M

RSI

39.09

TREND

Downtrend

IART Stock IQ

Login to see Integra LifeSciences (IART) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

IART Target Price

Login to display

Risk Analysis

IART Risk Analysis

Earnings are forecast to decrease

IART Risk Analysis

Downgraded on weak valued

Chart

$13.62 (-11.60%)

$14.19 (-15.15%)

$11.91 (+1.09%)

$23 (-47.65%)

1year

6month

3month

1month

IART Risk Level

IART has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Moderate

LOW

HIGH

IART Analysts Opinion

IART overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

IART Analysts Opinion

IART Analysts opinion is negative but has improved from the past 3 months

IART Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

67%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

0%

100%

33%

IART Street Sentiment

IART Street Sentiment is bullish but have mixed views on the near-term outlook

IART Performance Sentiment

Sentiments overview associated with IART events and the stock performance.

67%

27%

Positive

Negative

10 out of 15
events present

4 out of 15
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$11.22

Resistance
Price

$11.22

Current Price Range

$16.12

Show methods +

Linked to IART

IQ

Close Price

Change

SYK

3.99

373.42

+1.66%

PAVM

4.00

0.35

-8.49%

NMTC

3.50

0.68

-7.58%

BSX

4.29

104.98

+0.82%

IART Latest Analysis +

Integra LifeSciences Receives FDA Clearance For Cardiac Use Of CUSA Clarity System . (RTTNews) - Integra LifeSciences (IART) announced that it has received United States FDA 510(k) clearance for its CUSA Clarity Ultrasonic Surgical Aspirator System for use in cardiac surgery.

Wed Nov 12, 2025

$12.09 | -1.95%

Activity

Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries. PRINCETON N.J. Nov. 11 2025 (GLOBE NEWSWIRE) -- (Nasdaq: IART) a leading global medical technology company is pleased to announce the FDA 510(k) clearance for use of its ® Clarity Ultrasonic Surgical Aspirator System for cardiac surgeries. The recent clearance for specific cardiac indications encompasses the debridement of unwanted tissue in cardiac surgeri

Tue Nov 11, 2025

$12.33 | +1.23%

Activity

Integra LifeSciences stock jumps after FDA clearance for cardiac surgery device.

Tue Nov 11, 2025

$12.33 | +1.23%

Activity

Momentum

Truist Securities Reiterates Integra LifeSciences Holdings (IART) Hold Recommendation. Fintel reports that on November 3 2025 Truist Securities reiterated coverage of Integra LifeSciences Holdings (NasdaqGS:IART) with a Hold recommendation. Analyst Price Forecast Suggests 51.11% Upside

Tue Nov 4, 2025

$11.30 | -1.44%

Potential

Rating

Integra LifeSciences Q3 Adj. EPS Tops Estimates But Revenues Miss . (RTTNews) - Medical technology company Integra LifeSciences Holdings Corp. (IART) reported Thursday a net loss for the third quarter of $5.40 million or $0.07 per share narrower than $10.70 million or $0.14 per share in the prior-year quarter.

Thu Oct 30, 2025

$11.81 | -23.46%

Earnings

Integra LifeSciences Q3 Loss Narrows. Cuts FY25 Revenue Guidance. Stock Up . (RTTNews) - Integra LifeSciences Holdings Corp. (IART) a medical technology company Thursday reported narrower loss for the third quarter compared to the same period last year.

Thu Oct 30, 2025

$11.81 | -23.46%

Momentum

Potential

Integra LifeSciences (IART) Q3 Earnings Beat Estimates. Integra (IART) delivered earnings and revenue surprises of 25.58% and -3.07% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Thu Oct 30, 2025

$11.81 | -23.46%

Earnings

Integra LifeSciences Slashes FY25 Outlook - Update . (RTTNews) - While reporting financial results for the third quarter on Thursday medical technology company Integra LifeSciences Holdings Corp. (IART) slashed its adjusted earnings and revenue guidance for the for the full-year 2025.

Thu Oct 30, 2025

$11.81 | -23.46%

Potential

Integra LifeSciences Reports Third Quarter 2025 Financial Results. PRINCETON N.J. Oct. 30 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:) a leading global medical technology company today reported financial results for the third quarter ending September 30 2025.Third quarter revenues of $402.1 million increased 5.6% on a reported basis and 5.0% on an organic basis compared to the prior year. Third quarter GAAP earnings per diluted share of $(0.07) compared to $(0.14)

Thu Oct 30, 2025

$11.81 | -23.46%

Activity

Integra LifeSciences Holdings Corporation Non-GAAP EPS of $0.54 beats by $0.11 revenue of $402.06M misses by $12.25M.

Thu Oct 30, 2025

$11.81 | -23.46%

Earnings

FAQ About IART Stock Insights

What is IART current stock price?

What are IART stock strengths?

What risks are associated with IART stock?

When is IART next earnings report?

What is IART market cap and volume?

What is IART's current Stock IQ?

Should I buy IART stock right now?

Is IART a Strong Buy right now?

What does a 'Strong Buy' rating mean for IART?

What does a 'Strong Sell' rating mean for IART?

What factors influence IART's Stock IQ?

Explore our IART Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored IART Stock Strategies
Effective Risk Management

FIND US ON

Receive our IART Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

IART

Integra LifeSciences

Current Price

$12.04

-$0.05 | -0.41%

52W High

$ 27.13

MKT CAP

$ 937.82M

52W Low

$ 10.87

VOL

$ 836.18K

P/E Ratio

N/A

AVG VOL

$ 1.17M

RSI

39.09

TREND

Downtrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Risk Analysis

IART Risk Analysis

Earnings are forecast to decrease

IART Risk Analysis

Downgraded on weak valued

Linked to IART

Symbol

IQ

Close

Change

SYK

3.99

373.42

+1.66%

PAVM

4.00

0.35

-8.49%

NMTC

3.50

0.68

-7.58%

BSX

4.29

104.98

+0.82%

IART Stock IQ

Login to unlock Integra LifeSciences (IART) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$13.62 (-11.60%)

$14.19 (-15.15%)

$11.91 (+1.09%)

$23 (-47.65%)

1year

6month

3month

1month

IART Analysts Opinion

IART Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

IART Analysts Opinion

IART Analysts opinion is negative but has improved from the past 3 months

IART Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

67%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

0%

100%

33%

IART Street Sentiment

IART Street Sentiment is bullish but have mixed views on the near-term outlook

IART Risk Level

IART has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Moderate

LOW

HIGH

IART Performance Sentiment

Sentiments overview associated with IART events and the stock performance.

67%

27%

Positive

Negative

10 out of 15
events present

4 out of 15
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$11.22

Resistance
Price

$11.22

Current Price Range

$16.12

Show methods +

IART Latest Analysis

Integra LifeSciences Receives FDA Clearance For Cardiac Use Of CUSA Clarity System . (RTTNews) - Integra LifeSciences (IART) announced that it has received United States FDA 510(k) clearance for its CUSA Clarity Ultrasonic Surgical Aspirator System for use in cardiac surgery.

Wed Nov 12, 2025

$12.09 | -1.95%

Activity

Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries. PRINCETON N.J. Nov. 11 2025 (GLOBE NEWSWIRE) -- (Nasdaq: IART) a leading global medical technology company is pleased to announce the FDA 510(k) clearance for use of its ® Clarity Ultrasonic Surgical Aspirator System for cardiac surgeries. The recent clearance for specific cardiac indications encompasses the debridement of unwanted tissue in cardiac surgeri

Tue Nov 11, 2025

$12.33 | +1.23%

Activity

Integra LifeSciences stock jumps after FDA clearance for cardiac surgery device.

Tue Nov 11, 2025

$12.33 | +1.23%

Activity

Momentum

Truist Securities Reiterates Integra LifeSciences Holdings (IART) Hold Recommendation. Fintel reports that on November 3 2025 Truist Securities reiterated coverage of Integra LifeSciences Holdings (NasdaqGS:IART) with a Hold recommendation. Analyst Price Forecast Suggests 51.11% Upside

Tue Nov 4, 2025

$11.30 | -1.44%

Potential

Rating

Integra LifeSciences Q3 Adj. EPS Tops Estimates But Revenues Miss . (RTTNews) - Medical technology company Integra LifeSciences Holdings Corp. (IART) reported Thursday a net loss for the third quarter of $5.40 million or $0.07 per share narrower than $10.70 million or $0.14 per share in the prior-year quarter.

Thu Oct 30, 2025

$11.81 | -23.46%

Earnings

Integra LifeSciences Q3 Loss Narrows. Cuts FY25 Revenue Guidance. Stock Up . (RTTNews) - Integra LifeSciences Holdings Corp. (IART) a medical technology company Thursday reported narrower loss for the third quarter compared to the same period last year.

Thu Oct 30, 2025

$11.81 | -23.46%

Momentum

Potential

Integra LifeSciences (IART) Q3 Earnings Beat Estimates. Integra (IART) delivered earnings and revenue surprises of 25.58% and -3.07% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Thu Oct 30, 2025

$11.81 | -23.46%

Earnings

Integra LifeSciences Slashes FY25 Outlook - Update . (RTTNews) - While reporting financial results for the third quarter on Thursday medical technology company Integra LifeSciences Holdings Corp. (IART) slashed its adjusted earnings and revenue guidance for the for the full-year 2025.

Thu Oct 30, 2025

$11.81 | -23.46%

Potential

Integra LifeSciences Reports Third Quarter 2025 Financial Results. PRINCETON N.J. Oct. 30 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:) a leading global medical technology company today reported financial results for the third quarter ending September 30 2025.Third quarter revenues of $402.1 million increased 5.6% on a reported basis and 5.0% on an organic basis compared to the prior year. Third quarter GAAP earnings per diluted share of $(0.07) compared to $(0.14)

Thu Oct 30, 2025

$11.81 | -23.46%

Activity

Integra LifeSciences Holdings Corporation Non-GAAP EPS of $0.54 beats by $0.11 revenue of $402.06M misses by $12.25M.

Thu Oct 30, 2025

$11.81 | -23.46%

Earnings

Discover IART Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of IART. We're here to help you make informed investment decisions today.

FIND US ON

Receive our IART Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

IART Stock trends

IART Stock performance

IART Stock analysis

IART investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing IART

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing IART

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

IART Stock Analysis & IQ Rating | Integra LifeSciences

IART Stock IQ

IART Target Price

IART Risk Level

IART Analysts Opinion

IART Street Sentiment

IART Performance Sentiment

Technical Price Levels

Explore our IART Stock insights

Receive our IART Daily Alerts

IART Stock IQ

IART Street Sentiment

IART Risk Level

Technical Price Levels

Discover IART Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of IART. We're here to help you make informed investment decisions today.

Receive our IART Daily Alerts

IART Runner Alarm